Topics
Glioblastoma | Treatment | Chemotherapy | Neoadjuvant
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Neoadjuvant
Bazer DA, Wolff AC, Grossman SA.
Using
a Pre-Radiation Window to Identify Potentially Active Cytotoxic
Agents in Adults with Newly Diagnosed Glioblastoma.
Neuro
Oncol. 2024 Nov 13:noae240. doi:
10.1093/neuonc/noae240. PMID:
39535058. Review˰ ˍ
*Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B,
Naderi S, Khalilian A, Pourrashidi A, Amjad G, Kolahdouzan K,
Abyaneh R, Jablonska PA, Ghalehtaki R.
Postoperative
NEOadjuvant TEMozolomide followed by
chemoradiotherapy versus upfront
chemoradiotherapy for glioblastoma multiforme
(NEOTEM) trial: Interim results.
Neurooncol
Adv. 2024 Nov 14;6(1):vdae195. doi:
10.1093/noajnl/vdae195. PMID:
39664679. Interventional study. ˍ